NCT05378464 2026-01-08
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Recruiting
Clinical Trials
4 trialsNCT03690986 2025-07-23
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
Emory University
Phase 1 Recruiting
NCT04815720 2025-01-08
KEYNOTE-B84
Vaccinex Inc.
Phase 1/2 Completed
NCT03320330 2024-07-15
Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors
Children's Oncology Group
Phase 1/2 Completed